South San Francisco, CA
Escape Bio, Inc. operates as a preclinical stage biopharmaceutical company. The Company discovers and develops small molecule drugs and medicines to treat genetically-defined subpopulations in neurodegenerative diseases. Escape Bio serves customers in the State of California.
escapebio.comThese are collections ESCAPE Bio is a part of. Click on the collection name to view similar companies.
Series B
$73,000,000
Series Unknown
$31,073,380
Series A
$63,000,000
Series Unknown
$20,002,700
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ESCAPE Bio.